{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:06:38Z","timestamp":1760745998270,"version":"build-2065373602"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Major Scientific Instrument and Equipment Development Project","award":["2012YQ220113"],"award-info":[{"award-number":["2012YQ220113"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"DOI":"10.1007\/s00423-025-03862-x","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T02:54:49Z","timestamp":1760669689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Construction and validation of a novel prognostic model for postoperative patients with stage I intrahepatic cholangiocarcinoma: a population-based study"],"prefix":"10.1007","volume":"410","author":[{"given":"Xiaomeng","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinru","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huabang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"3862_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"3862_CR2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou M, Wang H, Zeng X et al (2019) Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet 394:1145\u20131158","journal-title":"Lancet"},{"key":"3862_CR3","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.21037\/tcr-23-1278","volume":"12","author":"JQ Yang","year":"2023","unstructured":"Yang JQ, Wang XG, Wu B (2023) Incidence trend and prognosis of intrahepatic cholangiocarcinoma: a study based on the SEER database. Transl Cancer Res 12:3007\u20133015","journal-title":"Transl Cancer Res"},{"key":"3862_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21037\/hbsn.2017.01.02","volume":"6","author":"A Gupta","year":"2017","unstructured":"Gupta A, Dixon E (2017) Epidemiology and risk factors: intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr 6:101\u2013104","journal-title":"Hepatobiliary Surg Nutr"},{"key":"3862_CR5","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","volume":"21","author":"SK Saha","year":"2016","unstructured":"Saha SK, Zhu AX, Fuchs CS et al (2016) Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise. Oncologist 21:594\u2013599","journal-title":"Oncologist"},{"key":"3862_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12885-022-09448-w","volume":"22","author":"Q Li","year":"2022","unstructured":"Li Q, Chen C, Su J et al (2022) Recurrence and prognosis in intrahepatic cholangiocarcinoma patients with different etiology after radical resection: a multi-institutional study. BMC Cancer 22:329","journal-title":"BMC Cancer"},{"key":"3862_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","volume":"149","author":"MN Mavros","year":"2014","unstructured":"Mavros MN, Economopoulos KP, Alexiou VG et al (2014) Treatment and prognosis for patients with intrahepatic cholangiocarcinoma. JAMA Surg 149:565\u2013574","journal-title":"JAMA Surg"},{"key":"3862_CR8","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1245\/s10434-010-0938-y","volume":"17","author":"SY Cho","year":"2010","unstructured":"Cho SY, Park SJ, Kim SH et al (2010) Survival analysis of intrahepatic cholangiocarcinoma after resection. Ann Surg Oncol 17:1823\u20131830","journal-title":"Ann Surg Oncol"},{"key":"3862_CR9","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ejso.2012.02.185","volume":"38","author":"ZF Wu","year":"2012","unstructured":"Wu ZF, Zhang HB, Yang N et al (2012) Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: results of a large monocentric series. Eur J Surg Oncol 38:602\u2013610","journal-title":"Eur J Surg Oncol"},{"key":"3862_CR10","doi-asserted-by":"crossref","unstructured":"Choi WJ, Williams PJ, Claasen M et al (2022) Systematic review and meta-analysis of prognostic factors for early recurrence in intrahepatic cholangiocarcinoma after curative-intent resection. Ann Surg Oncol Feb 18.","DOI":"10.1016\/j.ijsu.2022.106335"},{"key":"3862_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jamcollsurg.2016.05.019","volume":"223","author":"A Doussot","year":"2016","unstructured":"Doussot A, Gonen M, Wiggers JK et al (2016) Recurrence patterns and Disease-Free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic models. J Am Coll Surg 223:493\u2013505e2","journal-title":"J Am Coll Surg"},{"key":"3862_CR12","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB et al (2017) The Eighth Edition <scp>AJCC<\/scp>Cancer Staging Manual: Continuing to build a bridge from a population\u2010based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin 67:93\u201399","journal-title":"CA Cancer J Clin"},{"key":"3862_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","volume":"79","author":"European Association for the Study of the Liver","year":"2023","unstructured":"European Association for the Study of the Liver (2023) EASL-ILCA clinical practice guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol 79:181\u2013208","journal-title":"J Hepatol"},{"key":"3862_CR14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.6004\/jnccn.2023.0035","volume":"21","author":"AB Benson","year":"2023","unstructured":"Benson AB, D\u2019Angelica MI, Abrams T et al (2023) NCCN guidelines\u00ae insights: biliary tract cancers, version 2.2023. J Natl Compr Canc Netw 21:694\u2013704","journal-title":"J Natl Compr Canc Netw"},{"key":"3862_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/gutjnl-2023-330029","volume":"73","author":"SM Rushbrook","year":"2023","unstructured":"Rushbrook SM, Kendall TJ, Zen Y et al (2023) British society of gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma. Gut 73:16\u201346","journal-title":"Gut"},{"key":"3862_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/bjs\/znac098","volume":"109","author":"T Wei","year":"2022","unstructured":"Wei T, Zhang XF, He J et al (2022) Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study. Br J Surg 109:610\u2013616","journal-title":"Br J Surg"},{"key":"3862_CR17","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/bjs.10676","volume":"105","author":"XF Zhang","year":"2018","unstructured":"Zhang XF, Beal EW, Bagante F et al (2018) Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. Br J Surg 105:848\u2013856","journal-title":"Br J Surg"},{"key":"3862_CR18","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1245\/s10434-022-12463-7","volume":"30","author":"L Alaimo","year":"2023","unstructured":"Alaimo L, Moazzam Z, Brown ZJ et al (2023) Application of hazard function to investigate recurrence of intrahepatic cholangiocarcinoma after curative-intent liver resection: a novel approach to characterize recurrence. Ann Surg Oncol 30:1340\u20131349","journal-title":"Ann Surg Oncol"},{"key":"3862_CR19","doi-asserted-by":"publisher","first-page":"107327481772924","DOI":"10.1177\/1073274817729241","volume":"24","author":"YS Chun","year":"2017","unstructured":"Chun YS, Javle M (2017) Systemic and adjuvant therapies for intrahepatic cholangiocarcinoma. Cancer Control 24:1073274817729241","journal-title":"Cancer Control"},{"key":"3862_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.gassur.2023.10.002","volume":"28","author":"J Kawashima","year":"2024","unstructured":"Kawashima J, Sahara K, Shen F et al (2024) Predicting risk of recurrence after resection of stage I intrahepatic cholangiocarcinoma. J Gastrointest Surg 28:18\u201325","journal-title":"J Gastrointest Surg"},{"key":"3862_CR21","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3350\/cmh.2024.0318","volume":"30","author":"D Kim","year":"2024","unstructured":"Kim D, Manikat R, Wijarnpreecha K et al (2024) Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018\u20132023. Clin Mol Hepatol 30:756\u2013770","journal-title":"Clin Mol Hepatol"},{"key":"3862_CR22","first-page":"214","volume":"38","author":"R Medha","year":"2025","unstructured":"Medha R, Sreeram P, Daaboul O et al (2025) Forty-five-year trends in intra- and extrahepatic cholangiocarcinoma: sex- and race-based insights. Ann Gastroenterol 38:214\u2013220","journal-title":"Ann Gastroenterol"},{"key":"3862_CR23","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/hepr.12605","volume":"46","author":"S Mosadeghi","year":"2016","unstructured":"Mosadeghi S, Liu B, Bhuket T et al (2016) Sex-specific and race\/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the USA: an updated analysis of the 2000\u20132011 surveillance, epidemiology and end results registry. Hepatol Res 46:669\u2013677","journal-title":"Hepatol Res"},{"key":"3862_CR24","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1007\/s10620-018-5077-5","volume":"63","author":"J Shen","year":"2018","unstructured":"Shen J, Liu J, Li C et al (2018) The impact of tumor differentiation on the prognosis of HBV-associated solitary hepatocellular carcinoma following hepatectomy: a propensity score matching analysis. Dig Dis Sci 63:1962\u20131969","journal-title":"Dig Dis Sci"},{"key":"3862_CR25","doi-asserted-by":"publisher","first-page":"19267","DOI":"10.1038\/s41598-023-45056-9","volume":"13","author":"Y Lv","year":"2023","unstructured":"Lv Y, Liu H, He P et al (2023) A novel model for predicting the prognosis of postoperative intrahepatic cholangiocarcinoma patients. Sci Rep 13:19267","journal-title":"Sci Rep"},{"key":"3862_CR26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/jhbp.543","volume":"25","author":"SH Kang","year":"2018","unstructured":"Kang SH, Hwang S, Lee YJ et al (2018) Prognostic comparison of the 7th and 8th editions of the American Joint Committee on Cancer staging system for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 25:240\u2013248","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"3862_CR27","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/jso.24569","volume":"115","author":"G Spolverato","year":"2017","unstructured":"Spolverato G, Bagante F, Weiss M et al (2017) Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma. J Surg Oncol 115:696\u2013703","journal-title":"J Surg Oncol"},{"key":"3862_CR28","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s11605-019-04185-1","volume":"24","author":"Y Yamamoto","year":"2020","unstructured":"Yamamoto Y, Sugiura T, Okamura Y et al (2020) The evaluation of the eighth edition of the AJCC\/UICC staging system for intrahepatic cholangiocarcinoma: a proposal of a modified new staging system. J Gastrointest Surg 24:786\u2013795","journal-title":"J Gastrointest Surg"},{"key":"3862_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00432-025-06148-3","volume":"151","author":"R Zhang","year":"2025","unstructured":"Zhang R, Cao D, Yang M et al (2025) Should lymphadenectomy be recommended in radical surgery of intrahepatic cholangiocarcinoma patients? A retrospective study. J Cancer Res Clin Oncol 151:107","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"3862_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00423-024-03564-w","volume":"410","author":"J Yoshino","year":"2024","unstructured":"Yoshino J, Nara S, Yokoyama M et al (2024) Prognostic impact of lymph node dissection in intrahepatic cholangiocarcinoma: a propensity score analysis. Langenbecks Arch Surg 410(1):3","journal-title":"Langenbecks Arch Surg"},{"key":"3862_CR31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.14740\/wjon1895","volume":"15","author":"M Sha","year":"2024","unstructured":"Sha M, Cao J, Qin CL et al (2024) Impact of lymph node dissection for patients with clinically node-negative intrahepatic cholangiocarcinoma: a multicenter cohort study. World J Oncol 15:579\u2013591","journal-title":"World J Oncol"},{"issue":"2","key":"3862_CR32","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jhep.2022.10.021","volume":"78","author":"C Sposito","year":"2023","unstructured":"Sposito C, Ratti F, Cucchetti A et al (2023) Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma. J Hepatol 78(2):356\u2013363","journal-title":"J Hepatol"},{"key":"3862_CR33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.21037\/hbsn.2019.06.12","volume":"9","author":"AM Altman","year":"2020","unstructured":"Altman AM, Kizy S, Marmor S et al (2020) Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: approaching clinical practice consensus? Hepatobiliary Surg Nutr 9:577\u2013586","journal-title":"Hepatobiliary Surg Nutr"},{"key":"3862_CR34","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1245\/s10434-020-09393-7","volume":"28","author":"DI Tsilimigras","year":"2021","unstructured":"Tsilimigras DI, Hyer JM, Paredes AZ et al (2021) Tumor burden dictates prognosis among patients undergoing resection of intrahepatic cholangiocarcinoma: a tool to guide Post-Resection adjuvant chemotherapy?? Ann Surg Oncol 28:1970\u20131978","journal-title":"Ann Surg Oncol"},{"key":"3862_CR35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.21873\/cdp.10090","volume":"2","author":"SI Ariizumi","year":"2022","unstructured":"Ariizumi SI, Yamamoto M, Kotera Y et al (2022) Intrahepatic cholangiocarcinoma with neither intrahepatic metastasis nor lymph node metastasis is the optimal indication for hepatectomy with adjuvant therapy. Cancer Diagnosis & Prognosis 2:160\u2013166","journal-title":"Cancer Diagnosis & Prognosis"},{"key":"3862_CR36","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1186\/s12885-022-10269-0","volume":"22","author":"XH Li","year":"2022","unstructured":"Li XH, Zhao CY, Zhou EL et al (2022) Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection. BMC Cancer 22:1159","journal-title":"BMC Cancer"},{"key":"3862_CR37","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.ejso.2019.03.023","volume":"45","author":"S Yadav","year":"2019","unstructured":"Yadav S, Xie H, Bin-Riaz I et al (2019) Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: a propensity score matched analysis. Eur J Surg Oncol 45:1432\u20131438","journal-title":"Eur J Surg Oncol"},{"key":"3862_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/jso.27743","volume":"130","author":"CJ Wehrle","year":"2024","unstructured":"Wehrle CJ, Chang J, Woo K et al (2024) Neoadjuvant therapy reduces node positivity but does not confer survival benefit versus up-front resection for resectable intrahepatic cholangiocarcinoma: a propensity-matched analysis. J Surg Oncol 130:453\u2013461","journal-title":"J Surg Oncol"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-025-03862-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-025-03862-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-025-03862-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T02:54:58Z","timestamp":1760669698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-025-03862-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3862"],"URL":"https:\/\/doi.org\/10.1007\/s00423-025-03862-x","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All clinical patients involved in this study have signed the informed consent form. And this study adopted a retrospective design, with all patient data subjected to de-identification procedures to ensure robust protection of personal privacy. Ethical approval was waived following confirmation by the Ethics Committee of the Third Affiliated Hospital of Naval Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval disclosure"}},{"value":"All authors have no conflicts of interest or financial ties to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author disclosures"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"303"}}